Prof. Dr. med. Claus Cursiefen - Augenheilkunde, Köln - Publikationen

1. Cursiefen C, Beer M, Altunbas A. Should all medical students do research during their studies? Med Educ 1995;29:254      

2. Cursiefen C, Schönherr U. Angiogenesis and anhibition of angiogenesis in the eye Klin Monbl. Augenheilkd 1997 Jun;210(6):341-51 
   
3. Cursiefen C, Grunert U, Jünemann A. Chloroquin-induzierte Schießscheiben-Makulopathie ohne elektrophysiologische Veränderungen. Klin. Monatsbl. Augenheilkd. 1997;210:400-401 

4. Cursiefen C, Händel A, Schönherr U, Naumann GO. Das Pseudoexfoliationssyndrom bei Patienten mit retinaler Venenast- und Zentralvenenthrombose. Klin Monatsbl Augenheilkd 1997;211:17-21 

5. Cursiefen C, Küchle M, Scheurlen W, Naumann GOH. Bilateral zonular cataract associated with the mitochondrial cytopathy of Pearson. Am J Ophthalmol 1998;125:260-261

6. Cursiefen C, Holbach LM. Molluscum contagiosum bei Immunsuppression mit Methotrexat. Klin Monatsbl Augenheilkd 1998;212:123-124   Altunbas A, Cursiefen C. Forschungsaktivität von Medizinstudenten in Deutschland am Beispiel der Universitätsklinik Würzburg. Deutsche Medizinische Wochenschrift 1998;123:617-620

7. Keyvani K, Paulus W, Traupe H, Kiesewetter F, Cursiefen C, Huk W, Raab K, Orth U, Rauch A, Pfeiffer RA. Ichthyosis follicularis, alopecia, and photophobia (IFAP)-syndrome: clinical and neuropathological observations in a 33-year-old male. Am J Med Genetics 1998;78:371-377  

8. Cursiefen C, Altunbas A. Contribution of medical student research to the MedlineTM-indexed publications of a German medical Faculty. Med Educ 1998;32:439-40

9. Cursiefen C, Jünemann A. Subepidermal calcified nodule. Arch Ophthalmol 1998;116:1254-1255 
       
10. Cursiefen C, Küchle M, Naumann GOH. Angiogenesis in corneal diseases: histopathologic evaluation of 254 human corneal buttons with neovascularization  Cornea 1998Nov;17(6)611-3
  
11. Jonas JB, Cursiefen C, Budde WM. Normal-pressure glaucoma like optic neuropathy in teenager with ten years follow-up. Arch Ophthalmol 1998;116:1384-1386

12. Cursiefen C, Jünemann A, Korth M. Glaukom und Schwangerschaft - Literaturübersicht und Kasuistik. Klin Monatsbl Augenheilkd 1998;213:126-31 
  
13. Cursiefen C, Küchle M, Naumann GOH. Angiogenesis in corneal diseases: Histopathology of 254 human corneal buttons with neovascularization. Cornea 1998;17:611-613

14. Cursiefen C, Schlötzer-Schrehardt U, Holbach L, Naumann GOH. Adenoma of the nonpigmented ciliary body epithelium mimicking a malignant melanoma of the iris. Arch Ophthalmol 1999;117:113-116  
    
15. Küchle M, Cursiefen C, Fischer D-C, Schlötzer-Schrehardt U, Naumann GOH. Recurrent macular corneal dystrophy type II 49 years after penetrating keratoplasty. Arch Ophthalmol 1999;117:528-531 

16. Cursiefen C, Schlötzer-Schrehardt U, Holbach L, Pfeiffer R, Naumann GOH. Ocular findings in ichthyosis follicularis, atrichia, and photophobia (IFAP)-syndrome. Arch Ophthalmol 1999;117:681-684 

17. Cursiefen S, Flachenecker P, Rieckmann P, Toyka KV. Mitoxantrone (Novantron) in therapy of severe multiple sclerosis. A retrospective study of 15 patients]. Nervenarzt. 1999 Aug;70(8):723-31
        
18. Cursiefen C, Schönherr U, Schwender S, Grossmann R. Bilateral Optic Nerve Head Infarctions Associated with Combined Factor V:R506Q- and Factor II:G20210A-Mutation. Acta Ophthalmol Scand 1999;77:625-627 
    
19. Cursiefen C, Wisse M, Cursiefen S, Jünemann A, Martus P, Korth M. Migraine and tension-headache in high-pressure and normal-pressure glaucoma. Am J Ophthalmol 2000;129:102-104   
     
20. Cursiefen S, Flachenecker P, Toyka KV, Rieckmann P. Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis. Eur Neurol. 2000;43(3):186-7  
   
21. Korth MJ, Jünemann AM, Horn FK, Bergua A, Cursiefen C, Velten I, Budde WM, Wisse M, Martus P. Synopsis of various electrophysiological tests in early glaucoma diagnosis--temporal and spatiotemporal contrast sensitivity, light- and color-contrast pattern-reversal electroretinogram, blue-yellow VEP Klin Monbl Augenheilkd. 2000 Jun;216(6):360-8

22. Cursiefen C, Rummelt C, Küchle M. Immunohistochemical localization of VEGF, TGF and TGF1 in human corneas with neovascularization. Cornea 2000;9:526-533 

23. Cursiefen C, Horn F, Korth M. Reduced recovery of temporal contrast sensitivity after flicker stress in patients with glaucoma. J Glaucoma 2000;9:296-302 

24. Cursiefen C, Hofmann-Rummelt C, Schlötzer-Schrehardt U, Fischer DC, Küchle M. Immunphänotypische Klassifizierung der makulären Hornhautdystrophie: Erstbeschreibung des Immunphänotyps I A außerhalb Saudi-Arabiens. Eine klinisch-histopathologische Korrelation mit immunhistochemischen und elektronenmikroskopischen Befunden. Klin Monatsbl Augenheilkd 2000;217:118-126

25. Cursiefen C, Holbach LM, Lafaut B, Heimann K, Kirchner T, Naumann GOH. Oculocerebral non-Hodgkin’s lymphoma with uveal involvement: development of an epibulbar tumor after vitrectomy. Arch Ophthalmol 2000;118:1437-1440 

26. Colombo F, Cursiefen C, Holbach LM. Intraosseous cavernous hemangioma of the orbit. Am J Ophthalmol 2001;131:151-152     

27. Cursiefen C, Schlötzer-Schrehardt U, Holbach M, Vieth M, Kuchelmeister K, Stolte M. Ocular findings in Fryns syndrome. Acta Ophthalmol Scand 2000;78:710-13 

28. Budde M, Cursiefen C, Holbach L, Naumann GOH. Silicone oil-associated optic nerve degeneration. Am J Ophthalmol 2001;131:392-394  

29. Colombo F, Cursiefen C, Holbach LM. Breast carcinoma metastatic to the eyelid presenting as the first sign of insufficient chemotherapy. Opthalmologica 2001;215:136-137 

30. Nguyen NX, Langenbucher A, Seitz B, Graupner M, Cursiefen C, Kuchle M, Naumann GOH. Blood-aqueous barrier breakdown after penetrating keratoplasty with simultaneous extracapsular cataract extraction and posterior chamber lens implantation. Graefe’s Arch Clin Exp Ophthalmol 2001;239:114-117

31. Cursiefen C, Holbach L, Schlötzer-Schrehardt U, Naumann GOH. Persisting retinal ganglion cell axons in blind atrophic human eyes. Graefe’s Arch Clin Exp Ophthalmol 2001;239:158-164    
 
32. Krist D, Cursiefen C, Jünemann A. Intermittierende intrathorakale und –abdominale Druckerhöhungen beim Normaldruckglaukom. Klin Monatsbl Augenheilkd 2001;218:271-278       
   
33. Cursiefen C, Wenkel H, Langenbucher A, Martus P, Seitz B, Küchle M. Standardisiertes Beurteilungsschema zur semiquantitativen Analyse der kornealen Neovaskularisation mittels projizierter Hornhautphotographien: Pilotstudie zur Analyse der kornealen Neovaskularisation nach Nicht-Hochrisiko-Keratoplastik vor anschließender Immunreaktion. Klin Monatsbl Augenheilkd 2001;218:484-491 

34. Nguyen N, Langenbucher A, Cursiefen C, Seitz B, Wenkel H. Küchle M. Entwicklung von Visus und intraokularem Druck bei endothelialer Immunreaktion nach perforierender Keratoplastik. Klin Monatsbl Augenheilkd 2001;218:492-497  

35. Cursiefen C, Wenkel H, Martus P, Langenbucher A, Seitz B, Nguyen N, Küchle M, Naumann GOH. Peripheral corneal neovascularization after non-high risk-keratoplasty: influence of short- versus longtime topical steroids. Graefe’s Arch Clin Exp Ophthalmol 2001;239: 514-521  
     
36. Colombo F, Cursiefen C, Neukamm FW, Holbach L. Orbital involvement in cherubism. Ophthalmology 2001;108:1884-1888     

37. Cursiefen C, Rummelt C, Breiteneder S, Schlötzer-Schrehardt U, Holbach L. Orbital lymphangioma with positive immunohistochemistry of lymphatic endothelial markers (VEGF R3, Podoplanin). Graefe’s Arch Clin Exp Ophthalmol 2001;239:628-32

38. Cursiefen C, Hammer T, Küchle M, Schlötzer-Schrehardt U, Naumann GOH. Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion. Acta Ophthalmol Scand 2001;76:476-478    
 
39. Cursiefen C, Korth M, Horn F. The negative response of the photopic flash electroretinogram. Doc Ophthalmol 2001;103:1-12   

40. Seitz B, Langenbucher A, Diamantis A, Cursiefen C, Küchle M, Naumann GOH. Immunreaktionen nach perforierender Keratoplastik – Eine prospektive randomisierte Verleichsstudie zwischen Excimerlaser und Motortrepanation. Klin Monatsbl Augenheilkd 2001;218:710-719    
    
41. Cursiefen C, Hofmann-Rummelt C, Schlötzer-Schrehardt U, Fischer DC, Haubeck HD, Küchle M, Naumann GO. Immunohistochemical classification of primary and recurrent macular corneal dystrophy in Germany: subclassification of immunophenotype I A using a novel keratan sulfate antibody. Exp Eye Res. 2001 Nov;73(5):593-600. 

42. Holbach L, Cursiefen C, Jünemann A, Viestenz A, Nasr A. Differential eyelid tumor diagnosis I Klin. Monbl. Augenheilkd. 2002 May;219 (5) 394-411
 
43. Cursiefen C, Schlötzer-Schrehardt U, Küchle M, Sorokin L, Breitender-Geleff S, Alitalo K, Jackson D. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and Podoplanin. Invest Ophthalmol Vis Sci 2002;43:2127-213

44. Viestenz A, Cursiefen C, Küchle M. Bilateraler Nävus der Karunkel. Klin Monatsbl Augenheilkd 2002;219:380-382      

45. Nguyen N, Horn F, Seitz B, Cursiefen C, Martus P, Langenbucher A, Küchle M. Temporal contrast sensitivity using full-field flicker test in patients after penetrating keratoplasty. Graefe's Arch Clin Exp Ophthalmol 2002;240:443-447   

46. Küchle M, Cursiefen C, Nguyen NX, Langenbucher A, Seitz B, Wenkel H, Martus P, Naumann GOH. Risk factors for corneal allograft rejection: intermediate results of a prospective normal-risk keratoplasty study. Graefe’s Arch Clin Exp Ophthalmol 2002;240:580-584 
       
47. Cursiefen C, Grunke M, Dechant C, Antoni C, Jünemann A, Holbach LM. Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFalpha-antibody and methotrexate therapy. Am J Ophthalmol 2002;34:270-271   

48. Cursiefen C, Bergua A. Acute bilateral amaurosis secondary to fire-spitting: Methanol intoxication. Br J Ophthalmol 2002;86:1064-1065   
 
49. Cursiefen C, Martus P, Nguyen NX, Langenbucher A, Seitz B, Küchle M. Corneal neovascularization after nonmechanical versus mechanical corneal trephination for non-high-risk keratoplasty. Cornea 2002;21:648-652

50. Cursiefen C, Rummelt C, Küchle M, Schlötzer-Schrehardt U. Pericyte recruitment in human corneal angiogenesis. Br J Ophthalmol 2003;87:101-106  

51. Conway RM, Cursiefen C, Behrens J, Naumann GO, Holbach LM. Biomolecular markers of malignancy in human uveal melanoma: the role of the cadherin-catenin complex and gene expression profiling. Ophthalmologica. 2003 Jan-Feb;217(1):68-75.

52. Kottler UB, Cursiefen C, Holbach LM. Orbital involvement in multiple myeloma: first sign of insufficient chemotherapy. Ophthalmologica 2003;217:76-78

53. Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003 Apr;22(3):273-81 
       
54. Cursiefen C, Seitz B, Dana MR, Streilein JW. Angiogenesis and lymphangiogenesis in the cornea. Pathogenesis, clinical implications and treatment options Ophthalmologe. 2003 Apr;100(4):292-9. 
       
55. Flachenecker P, Schneider C, Cursiefen S, Ricker K, Toyka KV, Reiners K. Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM). Neuromuscul Disord. 2003 May;13(4):289-93   
 
56. Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GOH. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003;44:4473-80 
    
57. Kruse FE, Cursiefen C, Seitz B, Völcker HE, Naumann GO, Holbach L. Classification of ocular surface disease. Part 1. Ophthalmologe. 2003 Nov;100(11):899-915

58. Cursiefen C, Masli S, Ng TF, Dana MR, Bornstein P, Lawler J, Streilein JW. Roles of thrombospondin 1 and 2 in regulating spontaneous and induced angiogenesis in the cornea and iris. Invest Ophthalmol Vis Sci 2004;45:1117-24  
 
59. Cursiefen C, Chen L, Borges L, Jackson D, D’Amore PA, Dana MR, Wiegand SJ, Streilein JW. Via bone marrow-derived macrophages, VEGF A mediates lymph- and hemangiogenesis in inflammatory neovascularization. J Clin Investigation 2004;113:1040-50 
     
60. Nguyen NX, Horn FK, Seitz B, Cursiefen C, Kuchle M. Frequency-doubling perimetry in patients following penetrating keratoplasty. Cornea 2004;23:433-43 

61. Chen L, Hamrah P, Cursiefen C, Jackson D, Streilein JW, Dana MR. Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) mediates dendritic cell migration to lymph nodes and induction of immunity to corneal transplants. Nature Medicine 2004;10:813-5

62. Nguyen NX, Seitz B, Langenbucher A, Wenkel H, Cursiefen C. [Clinical aspects and treatment of immunological endothelial graft rejection following penetrating normal-risk keratoplasty]. Klin Monatsbl Augenheilkd 2004;221:467-72 
 
63. Cursiefen C, Maruyama K, Liu Y, Chen L, Jackson D, Wiegand S, Dana MR, Streilein JW. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 2004;45:2666-73 
       
64. Cursiefen C, Cao J, Chen L, Liu Y, Maruyama K, Jackson D, Kruse FE, Wiegand SJ, Dana MR, Streilein JW. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2666-73

65. Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR.  Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res 2004;79:553-61   

66. Cursiefen C, Seitz B, Kruse FE. Neurotrophic keratitis. Ophthalmologe. 2005 Jan;102(1):7-14 
       
67. Seitz B, Grüterich M, Cursiefen C, Kruse FE. Conservative and surgical treatment of neurotrophic keratopathy. Ophthalmologe. 2005 Jan;102(1):15-26
 
68. Schlötzer-Schrehardt U, Stojkovic M, Hofmann-Rummelt C, Cursiefen C, Kruse FE, Holbach LM. The pathogenesis of floppy eyelid syndrome: involvement of matrix metalloproteinases in elastic fiber degradation. Ophthalmology 2005;112:694-704

69. Cursiefen C, Ikeda S, Nishina PM, Smith RS, Ikeda A, Jackson D, Mo JS, Chen L, Dana RM, Pytowski B, Kruse FE, Streilein JW. Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3-signaling. Am J Pathol 2005;166: 1367-1377 

70. Maruyama K*, Li M*, Cursiefen C*, Keino H, Tomita M, Takenaka H, Jackson DG, Losordo DW, Streilein JW. Inflammatory lymphangiogenesis arises from CD11b+ cells. J Clin Invest 2004;15:2363-2372; *first authors  
  
71. Kuhlmann A, Amann K, Schlötzer-Schrehardt U, Kruse FE, Cursiefen C. Endothelin-1 and Eta/Etb-receptor protein and mRNA expression in normal and vascularized human corneas. Cornea 2005;24;837-844   
   
72. Chen L, Cursiefen C, Barabino S, Zhang, Q, Dana MR. Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol Vis Sci 2004;46:4536-40  

73. Cursiefen C, Jacobi C, Dietrich T, Kruse FE. Current treatment for dry eye syndrome Ophthalmologe. 2006 Jan;103(1):18-24.    
 
74. Jacobi C, Dietrich T, Cursiefen C, Kruse FE. The dry eye. Current concepts on classification, diagnostics, and pathogenesis. Ophthalmologe. 2006 Jan;103(1):9-17.

75. Vinh L, Nguyen N, Martus P, Seitz B, Kruse FE, Cursiefen C. Surgery-related factors influencing corneal neovascularization after low-risk keratoplasty. Am J Ophthalmol 2006;141:260-266        

76. Resch M, Schlötzer-Schrehardt U, Hofmann-Rummelt C, Sauer R, Cursiefen C, Kruse F, Beckmann M, Seitz B. Adhesion structures of amniotic membranes integrated into human corneas. Invest Ophthalmol Vis Sci 2006;47:1853-1861
   
77. Cursiefen C, Maryuama K, Jackson DG, Streilein JW, Kruse FE. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 2006;25:443-447

78. Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, Pytowski B, Persaud K, Streilein JW, Dana MR. Nonvascular VEGFR3 expression by corneal epithelium maintains avascularity and vision. Proc National Acad Sci USA 2006;103:11405-10

79. Gottschalk K, Rummelt C, Cursiefen C. [Conjunctival chemosis resistant to therapy.] Klin Monatsbl Augenheilkd 2006;223:696-8     

80. Cursiefen C, Rummelt C, Jünemann A, Vorwerk C, Neuhuber W, Kruse FE, Schroedl F. Absence of blood and lymphatic vessels in the developing human cornea.
Cornea 2006;25:722-6 
    
81. Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy. 2007;92:50-7. 
    
82. Bock F, König Y, Dietrich T, Zimmermann P, Baier M, Cursiefen C. Inhibition of angiogenesis in the anterior chamber of the eye Ophthalmologe. 2007 Apr;104(4):336-44.

83. Nguyen NX, Pham HN, Langenbucher A, Cursiefen C, Seitz B. Impact of short-term versus longterm topical steroid treatment on 'idiopathic' endothelial cell loss after normal-risk penetrating keratoplasty. Acta Ophthalmol Scand 2007;85:209-212 

84. Pollhammer M, Meiller R, Rummelt C, Thyzel R, Cursiefen C, Kruse FE. In situ ablation of lens epithelial cells in porcine eyes with the laser photolysis system. J Cataract Refract Surg 2007;33:697-701  
    
85. Cursiefen C, Rummelt C, Beckman MW, Kruse FE. Amniotic membrane-covered bio-onlays for treatment of ocular surface disease. Br J Ophthalmol 2006;91:841-2

86. Bock F, Onderka J, Dietrich T, Bachmann B, Kruse FE, Paschke M, Zahn G, Cursiefen C. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci 2007;48:2545-52
  
87. Dietrich T, Onderka J, Bock F, Kruse FE, Vossmeyer D, Straiges R, Zahn G, Cursiefen C. Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol 2007;171:361-72

88. Chen L, Hamrah P, Cursiefen C, Zhang Q, Pytowski B, Streilein JW, Dana MR. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Ocul Immunol Inflamm 2007;15:275-8 

89. Nguyen NX, Seitz B, Martus P, Langenbucher A, Cursiefen C. Long-term topical steroid treatment improves graft survival following  normal-risk penetrating keratoplasty. Am J Ophthalmol 2007;144:318-9  

90. Jacobi C, Wenkel H, Jacobi A, Korn K, Cursiefen C, Kruse FE. Hepatitis C and ocular surface disease. Am J Ophthalmol 2007;144:705-711

91. Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol 2008;246:115-9

92. Bock F, König Y, Kruse FE, Baier M, Cursiefen C. Bevacizumab (Avastin®) eye drops inhibit corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol 2008;246:281-4

93. Weisbach V, Dietrich T, Kruse FE, Eckstein R, Cursiefen C. HIV and Hepatitis-B/C infections in patients donating blood for use as autologous serum eye drops. Br J Ophthalmol 2008;91:1724-5
  
94. Förster CG, Langenbucher A, Cursiefen C, Kruse FE, Seitz B. Delayed epithelial healing after keratoplasty for lattice corneal dystrophy. Cornea 2007;26:1182-3. 

95. Bachmann B, Bock F, Wiegand S, Maruyama K, Dana R, Kruse FE, Luetjen-Drecoll E, Cursiefen C. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol 2008;126:71-7

96. Cursiefen C, Kruse FE. Descemet's stripping with automated endothelial keratoplasty (DSAEK) Ophthalmologe. 2008 Feb;105(2):183-90, 192.  

97. Förster CG, Cursiefen C, Kruse FE. [Topical application of EGF for the therapy of persisting corneal erosion under cetuximab treatment]. Ophthalmologe 2008;105:269-73

98. Heindl LM, Hofmann-Rummelt C, Schlötzer-Schrehardt U, Kruse FE, Cursiefen C. Histologic analysis of descemet’s stripping in posterior lamellar keratoplasty (DSAEK). Arch Ophthalmol 2008;126:461-4

99. Hos D, Bock F, Dietrich T, Onderka J, Kruse FE, Thierauch KH, Cursiefen C.  Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest Ophthalmol Vis Sci 2008;49:1836-42  
 
100. Kruse FE, Cursiefen C. Surgery of the cornea: corneal, limbal stem cell and amniotic membrane transplantation. Dev Ophthalmol. 2008;41:159-70.

101. Dietrich T, Weisbach V, Seitz B, Jacobi C, Kruse FE, Eckstein R, Cursiefen C. [Manufacture of autologous serum eye drops for out-patient therapy : Cooperation between ophthalmic clinic and transfusion medicine department.] Ophthalmologe 2008;105:1036-8,1040-2

102. Bachmann BO, Pogorelov P, Kruse FE, Cursiefen C. [Patient satisfaction after posterior lamellar keratoplasty (DSAEK)] Klin Monatsbl Augenheilkd 2008;225:577-81

103. Förster CG, Cursiefen C, Kruse FE. Persisting corneal erosion under cetuximab (Erbitux) treatment. Cornea 2008;27:612-4

104. Cursiefen C. Corneal crosslinking: "Safe and effective"? Ophthalmologe. 2009 Feb;106(2):164-5; author reply 165-6. German. 

105. Cursiefen S, Mäurer M. Current use of immunoglobulins in neurology. Nervenarzt. 2008 Sep;79 Suppl 2:67-74; quiz 75-6.

106. Schroedl F, Brehmer A, Neuhuber WL, Kruse FE, May CA, Cursiefen C. The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive macrophages. Invest Ophthalmol Vis Sci 2008;49:5222-9

107. Hos D, Bachmann B, Bock F, Onderka J, Cursiefen C. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis. Exp Eye Res 2008;87:427-32

108. Bock F, Onderka J, Hos D, Horn F, Martus P, Cursiefen C. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts.
Exp Eye Res 2008;87:462-70

109. Nguyen NX, Martus P, Seitz B, Cursiefen C. Atopic dermatitis as a risk factor for graft rejection following normal-risk keratoplasty. Graefes Arch Clin Exp Ophthalmol 2009;247:573-4

110. Regenfuss B, Bock F, Parthasarathy A, Cursiefen C. Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman. Lymphat Res Biol. 2008;6(3-4):191-201. 
    
111. Heindl LM, Hofmann TN, Knorr HL, Rummelt C, Schrödl F, Schlötzer-Schrehardt U, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci 2009;50:1988-95
 
112. Bock F, Onderka J, Rummelt C, Dietrich T, Bachmann B, Kruse FE, Schlötzer-Schrehardt U, Cursiefen C. Safety profile of topical VEGF neutralization at the cornea. Invest Ophthalmol Vis Sci. 2009 May;50(5):2095-102. Epub 2009 Jan 17.

113. Bachmann BO, Luetjen-Drecoll E, Bock F, Wiegand SJ, Hos D, Dana R, Kruse FE, Cursiefen C. Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation. Br J Ophthalmol 2009;93:1075-80 

114. Pogorelov P, Cursiefen C, Bachmann BO, Kruse FE. Changes in donor corneal lenticule thickness after Descemet's stripping automated endothelial keratoplasty (DSAEK) with organ-cultured corneas. Br J Ophthalmol 2009;93:825-9 

115. Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg 2009;35:588-9

116. Regenfuss B, Bock F, Bachmann B, König Y, Hos D, Parthasarathy A, Cursiefen C. Topical inhibition of angiogenesis at the cornea. Safety and efficacy]. Ophthalmologe. 2009 May;106(5):399-406   

117. Cursiefen C. Bevacizumab goes anterior: antiangiogenic therapy at cornea and conjunctiva Ophthalmologe. 2009 May;106(5):397-8 

118. Koenig Y, Bock F, Horn F, Kruse F, Straub K, Cursiefen C. Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2009;247:1375-82

119. Putzki N, Yaldizli O, Mäurer M, Cursiefen S, Kuckert S, Klawe C, Maschke M, Tettenborn B, Limmroth V. Efficacy of natalizumab in second line therapy of relapsing-remitting multiple sclerosis: results from a multi-center study in German speaking countries. Eur J Neurol. 2010 Jan;17(1):31-7. Epub 2009 Jul 9.

120. Zimmermann P, Dietrich T, Bock F, Horn FK, Hofmann-Rummelt C, Kruse FE, Cursiefen C. Tumor-associated lymphangiogenesis in conjunctival malignant melanoma. Br J Ophthalmol 2009;93:1529-34 

121. Cursiefen C, Bock F, Horn FK, Kruse FE, Seitz B, Borderie V, Früh B, Thiel MA, Wilhelm F, Geudelin B, Descohand I, Steuhl KP, Hahn A, Meller D. GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: Interim results of a randomized phase II trial. Ophthalmology 2009;116:1630-7

122. Heindl LM, Cursiefen C.  [Retained Descemet's membrane after penetrating keratoplasty for macular corneal dystrophy.] Ophthalmologe 2009;107:55-9 

123. Heindl LM, Hofmann TN, Adler W, Knorr HL, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology. 2010;117:334

124. Cursiefen C, Kruse FE; Erlanger DSAEK Gruppe. [Descemet's stripping automated endothelial keratoplasty (DSAEK)]. Ophthalmologe. 2009;106:939-52

125. Heindl LM, Hofmann-Rummelt C, Adler W, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology. 2010;117:649-58.
 
126. Jacobi C, Cursiefen C. Ophthalmological complications in Sjögren's syndrome Z Rheumatol. 2010 Feb;69(1):32-40. 

127. Dietrich T, Bock F, Yuen D, Hos D, Bachmann BO, Zahn G, Wiegand S, Chen L, Cursiefen C. Cutting edge: Lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol. 2010;184:535-9.

128. Lamparter J, Kottler U, Cursiefen C, Pfeiffer N, Pitz S.  [Morbus Morbihan : A rare cause of edematous swelling of the eyelids.] Ophthalmologe 2010;107:553-7

129. Preclik S, Langenbucher A, Seitz B, Cursiefen C. Langzeitverläufe nach perforierender Keratoplastik bei Keratokonus: Einfluß von präoperativem Astigmatismus und Visus. Klin Monatsbl Augenheilkd 2010;227:199-207

130. Bachmann BO, Laaser K, Cursiefen C, Kruse FE. A method to confirm correct orientation of descemet membrane during descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2010;149:922-925. 

131. Heindl LM, Hofmann-Rummelt C, Adler W, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma. Ophthalmology. 2010 Apr;117(4):649-58.

132. Heindl LM, Cursiefen C  Pterygium. Etiology, clinical aspects and novel adjuvant therapies Ophthalmologe. 2010 Jun;107(6):517-20, 522-4.

133. Jacobi C, Bellios N, Jacobi A, Kruse F, Cursiefen C. [Screening questionnaire for documentation of medical history and diagnostic findings in dry eye disease]. Klin Monbl Augenheilkd. 2011;228:226-33  

134. Sekundo W, Droutsas K, Cursiefen C. [Operative techniques for surgical treatment of primary and recurrent pterygia]. Ophthalmologe. 2010;107:525-8

135. Regenfuss B, Onderka J, Bock F, Hos D, Maruyama K, Cursiefen C. Genetic heterogeneity of lymphangiogenesis in different mouse strains. Am J Pathol. 2010;177:501-10  

136. Heindl LM, Kruse FE, Cursiefen C. [Complications after posterior lamellar keratoplasty (DSAEK): prevention, detection and treatment]. Klin Monbl Augenheilkd. 2010;227:478-82

137. Cursiefen C, Kruse FE. [DMEK: Descemet membrane endothelial keratoplasty]. Ophthalmologe. 2010;107:370-6

138. Bachmann B, Taylor RS, Cursiefen C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology. 2010;117:1300-5

139. Heindl LM, Hofmann TN, Schrödl F, Holbach LM, Kruse FE, Cursiefen C. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread? Arch Ophthalmol. 2010;128:1001-8

140. Heindl LM, Riss S, Bachmann BO, Laaser K, Kruse FE, Cursiefen C. Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology. 2011;118:294-301

141. Calabrese S, Wenkel H, Rummelt C, Kruse F, Cursiefen C. [Histopathology of retrocorneal membranes after keratoplasty]. Klin Monbl Augenheilkd. 2010;227:815-8

142. Kopsachilis N, Tsinopoulos I, Tourtas T, Kruse FE, Cursiefen C. Spontaneous resolution of corneal decompensation after big-bubble deep anterior lamellar keratoplasty with intraoperative Descemet's membrane perforation. Clin Experiment Ophthalmol. 2011;39:372-5   

143. Schramm A, Cursiefen S, Schröder R. Isolated ring-finger myoclonus. J Neurol. 2011 Jun;258(6):1164-5. Epub 2010 Nov 23.

144. Bock F, Regenfuss B, Cursiefen C. [Antiangiogenic therapy at the ocular surface: when, what and why?]. Ophthalmologe. 2011;108:230-6

145. Laaser K, Bachmann BO, Horn FK, Schlötzer-Schrehardt U, Cursiefen C, Kruse FE. Donor tissue culture conditions and outcome after descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2011;151:1007-1018  

146. Heindl LM, Schlötzer-Schrehardt U, Cursiefen C, Bachmann BO, Hofmann-Rummelt C, Kruse FE. Myofibroblast metaplasia after descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2011;151:1019-1023 

147. Hos D, Saban DR, Bock F, Regenfuss B, Onderka J, Masli S, Cursiefen C. Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol. 2011;129:445-52. 

148. Tourtas T, Kopsachilis N, Meiller R, Kruse FE, Cursiefen C. Pressure-induced interlamellar stromal keratitis after laser in situ keratomileusis. Cornea. 2011;30:920-3.

149. Heiligenhaus A, Cursiefen C. Special topic "inflammations of the eye in inflammatory systemic diseases”. Klin Monbl Augenheilkd. 2011 May;228(5):411-2. Epub 2011 Apr 29.

150.  Bachmann B, Jacobi C, Cursiefen C. Inflammation of the eye in systemic inflammatory disorders: keratitis. Klin Monbl Augenheilkd. 2011;228:413-8

151. Cursiefen C, Maruyama K, Bock F, Saban D, Sadrai Z, Lawler J, Dana R, Masli S. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med. 2011;208:1083-92

152. Kruse FE, Laaser K, Cursiefen C, Heindl LM, Schlötzer-Schrehardt U, Riss S, Bachmann BO. A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet membrane endothelial keratoplasty. Cornea. 2011;30:580-7

153. Hos D, Regenfuss B, Bock F, Onderka J, Cursiefen C. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis. Invest Ophthalmol Vis Sci. 20112;52:5778-85

154. Schlötzer-Schrehardt U, Bachmann BO, Laaser K, Cursiefen C, Kruse FE. Characterization of the cleavage plane in Descemet's membrane endothelial keratoplasty. Ophthalmology. 2011;118:1950-7

155. Cursiefen C, Colin J, Dana R, Diaz-Llopis M, Faraj LA, Garcia-Delpech S, Geerling G, Price FW, Remeijer L, Rouse BT, Seitz B, Udaondo P, Meller D, Dua H. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Br J Ophthalmol. 2011 Jun 28. [Epub ahead of print]

156. Jacobi C, Zhivov A, Korbmacher J, Falke K, Guthoff R, Schlötzer-Schrehardt U, Cursiefen C, Kruse FE. Evidence of endothelial cell migration after descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2011;152:537-542

157. Heindl LM, Riss S, Laaser K, Bachmann BO, Kruse FE, Cursiefen C. Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients. Am J Ophthalmol. 2011;152:523-532

158. Tourtas T, Kopsachilis N, Meiller R, Kruse FE, Cursiefen C. Pressure-induced interlamellar stromal keratitis after laser in situ keratomileusis. Cornea. 2011 Aug;30(8):920-3.

159. Braun JM, Hofmann-Rummelt C, Schlötzer-Schrehardt U, Kruse FE, Cursiefen C. Histopathological changes after deep anterior lamellar keratoplasty using the 'big-bubble technique' Acta Ophthalmol. 2011 Aug 11

160. Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Prognostic Significance of Tumor-Associated Lymphangiogenesis in Malignant Melanomas of the Conjunctiva. Ophthalmology. 2011 Aug 9. [Epub ahead of print]  

161. Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci. 2011;52(10):7074-83. 

162. Cursiefen C, Heindl LM. Perspectives of deep anterior lamellar keratoplasty Ophthalmologe. 2011 Sep;108(9):833-9.

163. Kruse FE, Laaser K, Cursiefen C, Heindl LM, Schlötzer-Schrehardt U, Riss S, Bachmann BO. A stepwise approach to donor preparation and insertion increases safety and outcome of descemet membrane endothelial keratoplasty. Cornea. 2011;30:580-7

164. Jacobi C, Jacobi A, Kruse FE, Cursiefen C. Tear film osmolarity measurements in dry eye disease using electrical impedance technology. Cornea. 2011;1289-92.

165. Steven P, Bock F, Hüttmann G, Cursiefen C. Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels. PLoS One. 2011;6:e 26253. 

166. Bachmann B, Cursiefen C. [Late complications after chemical burns of the ocular surface: Surgical strategies for ocular surface reconstruction]. Ophthalmologe. 2011;108:929-38.

167. Reimer A, Langenbucher A, Cursiefen C. [Long-Term Outcome after Penetrating Keratoplasty for Bullous Keratopathy - Influence of Preoperative Visual Acuity on Final Outcome.] Klin Monbl Augenheilkd. 2011 (in press)

168. Bachmann B, Taylor RS, Cursiefen C. The association between corneal neovascularization and visual acuity: a systematic review. Acta Ophthalmol. 2011 doi: 10.1111/j.1755-3768.2011.02312

169. Tourtas T, Cursiefen C. "PISK-itis" or "PISK-opathy"? Cornea. 2012 Feb;31(2):107.

170. Dietrich-Ntoukas T, Cursiefen C, Westekemper H, Eberwein P, Reinhard T, Bertz H, Nepp J, Lawitschka A, Heiligenhaus A, Seitz B, Messmer EM, Meyer-Ter-Vehn T, Basara N, Greinix H, Datiles MB, Lee SJ, Pavletic SZ, Wolff D. Diagnosis and Treatment of Ocular Chronic Graft-Versus-Host Disease: Report From the German-Austrian-Swiss Consensus Conference on Clinical Practice in Chronic GVHD. Cornea. 2011 Dec 6. [Epub ahead of print]     

171. Schrell C, Cursiefen C, Kruse F, Jacobi C. [Topical Cyclosporine A 0.05% in the Treatment of Keratoconjunctivitis Sicca.] Klin Monbl Augenheilkd. 2011 Dec 21. [Epub ahead of print] German.  

172. Rudolph M, Laaser K, Bachmann BO, Cursiefen C, Epstein D, Kruse FE. Corneal Higher-Order Aberrations after Descemet's Membrane Endothelial Keratoplasty. Ophthalmology. 2011 Dec 22. [Epub ahead of print]

173. Cloutier F, Lawrence M, Goody R, Lamoureux S, Al-Mahmood S, Colin S, Ferry A, Conduzorgues JP, Hadri A, Cursiefen C, Udaondo P, Viaud E, Thorin E, Chemtob S. Anti-angiogenic activity of Aganirsen in non-human primate and rodent models of retinal neovascular disease following topical administration. Invest Ophthalmol Vis Sci. 2012 Feb 9. [Epub ahead of print]

174. Riss S, Heindl LM, Bachmann BO, Kruse FE, Cursiefen C.Pentacam-based big bubble deep anterior lamellar keratoplasty in patients with keratoconus. Cornea. 2012 Jun;31(6):627-32.

175. Koenig Y, Bock F, Kruse FE, Stock K, Cursiefen C. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs Cornea. 2012 Aug;31(8):887-92.

176. Tourtas T, Laaser K, Bachmann BO, Cursiefen C, Kruse FE  Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2012 Jun;153(6):1082-90.e2. Epub 2012 Mar 6 

177. Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J; SOLAR Study Group A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 2012 Mar 13;78(11):841.  

178. Riss S, Heindl LM, Bachmann BO, Kruse FE, Cursiefen C. Microbubble Incision as a New Rescue Technique for Big-Bubble Deep Anterior Lamellar Keratoplasty With Failed Bubble Formation. Cornea. 2012 Mar 12.

179. Altenburger AE, Bachmann B, Seitz B, Cursiefen C. Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease. Graefes Arch Clin Exp Ophthalmol. 2012 Mar 15. [Epub ahead of print]

180. Laaser K, Bachmann BO, Horn FK, Cursiefen C, Kruse FE. Descemet membrane endothelial keratoplasty combined with phacoemulsification and intraocular lens implantation: advanced triple procedure. Am J Ophthalmol. 2012 Jul;154(1):47-55

181. Maruyama K, Nakazawa T, Cursiefen C, Maruyama Y, Van Rooijen N, D'Amore PA, Kinoshita S. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages. Invest Ophthalmol Vis Sci. 2012 May 31;53(6):3145-53

182. Heindl LM, Cursiefen C. [Split-cornea transplantation-a novel concept to reduce corneal donor shortage]. Klin Monbl Augenheilkd. 2012 Jun;229(6):608-14

183. Wessel JM, Hofmann-Rummelt C, Kruse FE, Cursiefen C, Heindl LM. Invasion of lymphatic vessels into the eye after open globe injuries. Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3717-25 

184. Heiligenhaus A, Cursiefen C. Special topic: inflammations of the ocular surface. Klin Monbl Augenheilkd. 2012 May;229(5):499. Epub 2012 May 16 

185. Steven P, Cursiefen C. Anti-inflammatory treatment in dry eye disease Klin Monbl Augenheilkd. 2012 May;229(5):500-5. Epub 2012 May 16.  

186. Rosentreter A, Athanasopoulos A, Schild AM, Lappas A, Cursiefen C, Dietlein TS. Rebound, Applanation, and Dynamic Contour Tonometry in Pathologic Corneas. Cornea. 2012 Jun 5. [Epub ahead of print] 

187. Jacobi C, Kruse FE, Cursiefen C. Prospective, Randomized, Controlled Comparison of SYSTANE UD(®) Eye Drops Versus VISINE INTENSIV 1% EDO(®) Eye Drops for the Treatment of Moderate Dry Eye. J Ocul Pharmacol Ther. 2012 Jul 19.

188. Regenfuss B, Bock F, Cursiefen C. Corneal angiogenesis and lymphangiogenesis. Curr Opin Allergy Clin Immunol. 2012 Oct;12(5):548-54. 

189. Bucher F, Parthasarathy A, Bergua A, Onderka J, Regenfuß B, Cursiefen C, Bock F. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis. Acta Ophthalmol. 2012 Sep 20.